Plain-English translation of NCT05025878 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →Researchers want to understand how cancer cells and immune cells in ovarian cancer patients use glucose for energy. This study uses a special type of glucose called [U-13C]glucose that can be tracked in the body to see which cells are using glucose and how. By collecting fluid samples during your routine drainage procedure, researchers hope to learn more about how these cells behave and what fuels them.
Right now, doctors don't fully understand the differences in how cancer cells versus immune cells use glucose in ovarian cancer. Learning this could help develop better treatments in the future that work with your body's immune system to fight cancer more effectively.
You likely qualify if…
You likely don't qualify if…
You will wear a continuous glucose monitor for a few days before your visit. On the day of your scheduled fluid drainage procedure at the hospital, you'll receive two infusions of the special labeled glucose through an IV — first a larger dose over 10 minutes, then a smaller dose over an hour. During and after the infusions, doctors will collect samples of the fluid being drained and analyze them to see how the cells are using the glucose. The entire process takes about 5 hours.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
Canada
Sponsor
British Columbia Cancer Agency
Collaborators
University of Texas Southwestern Medical Center, Van Andel Research Institute
Enrollment target
~10 participants
Started
October 2021
Primary completion
August 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Julian J. Lum, PhD
British Columbia Cancer Agency
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.